mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.16 |
0.4 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
-0.13 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.4 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BIRB 0796 |
FIMM |
pan-cancer |
AAC |
0.17 |
0.4 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.4 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |